New model of PIRADS and adjusted prostate-specific antigen density of peripheral zone improves the detection rate of initial prostate biopsy: a diagnostic study
Asian Journal of Andrology · 2023
DOI: 10.4103/aja202218 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Andrology, 2023. Verfasst von Chen Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China. Hauptthemen laut MEDLINE: Prostate, Prostatic Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This study explored a new model of Prostate Imaging Reporting and Data System (PIRADS) and adjusted prostate-specific antigen density of peripheral zone (aPSADPZ) for predicting the occurrence of prostate cancer (PCa) and clinically significant prostate cancer (csPCa). The demographic and clinical characteristics of 853 patients were recorded. Prostate-specific antigen (PSA), PSA density (PSAD), PSAD of peripheral zone (PSADPZ), aPSADPZ, and peripheral zone volume ratio (PZ-ratio) were calculated and subjected to receiver operating characteristic (ROC) curve analysis. The calibration and discrimination abilities of new nomograms were verified with the calibration curve and area under the ROC curve (AUC). The clinical benefits of these models were evaluated by decision curve analysis and clinical impact curves. The AUCs of PSA, PSAD, PSADPZ, aPSADPZ, and PZ-ratio were 0.669, 0.762, 0.659, 0.812, and 0.748 for PCa diagnosis, while 0.713, 0.788, 0.694, 0.828, and 0.735 for csPCa diagnosis, respectively. All nomograms displayed higher net benefit and better overall calibration than the scenarios for predicting the occurrence of PCa or csPCa. The new model significantly improved the diagnostic accuracy of PCa (0.945 vs 0.830, P < 0.01) and csPCa (0.937 vs 0.845, P < 0.01) compared with the base model. In addition, the number of patients with PCa and csPCa predicted by the new model was in good agreement with the actual number of patients with PCa and csPCa in high-risk threshold. This study demonstrates that aPSADPZ has a higher predictive accuracy for PCa diagnosis than the conventional indicators. Combining aPSADPZ with PIRADS can improve PCa diagnosis and avoid unnecessary biopsies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
- Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
- Department of Pathology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Zitieren
APA
Huang, C., Cai, Z. Q., Qiu, F., Pu, J. X., Xi, Q. L., Wei, X. D., Wang, X. M., Zhao, X. J., Guo, L. C., Hou, J. Q., & Huang, Y. H. (2023). New model of PIRADS and adjusted prostate-specific antigen density of peripheral zone improves the detection rate of initial prostate biopsy: a diagnostic study. Asian Journal of Andrology. https://doi.org/10.4103/aja202218
Vancouver
Huang C, Cai ZQ, Qiu F, Pu JX, Xi QL, Wei XD, et al. New model of PIRADS and adjusted prostate-specific antigen density of peripheral zone improves the detection rate of initial prostate biopsy: a diagnostic study. Asian Journal of Andrology. 2023. doi:10.4103/aja202218
BibTeX
@article{Huang2023,
author = {Huang, Chen and Cai, Zong-Qiang and Qiu, Feng and Pu, Jin-Xian and Xi, Qi-Lin and Wei, Xue-Dong and Wang, Xi-Ming and Zhao, Xiao-Jun and Guo, Lin-Chuan and Hou, Jian-Quan and Huang, Yu-Hua},
title = {New model of PIRADS and adjusted prostate-specific antigen density of peripheral zone improves the detection rate of initial prostate biopsy: a diagnostic study},
journal = {Asian Journal of Andrology},
year = {2023},
doi = {10.4103/aja202218}
}
EUVIMED